GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SSY Group Ltd (HKSE:02005) » Definitions » Price-to-Free-Cash-Flow

SSY Group (HKSE:02005) Price-to-Free-Cash-Flow : 64.59 (As of May. 03, 2024)


View and export this data going back to 2005. Start your Free Trial

What is SSY Group Price-to-Free-Cash-Flow?

As of today (2024-05-03), SSY Group's share price is HK$4.78. SSY Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.07. Hence, SSY Group's Price-to-Free-Cash-Flow Ratio for today is 64.59.

The historical rank and industry rank for SSY Group's Price-to-Free-Cash-Flow or its related term are showing as below:

HKSE:02005' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 19.13   Med: 52.59   Max: 150.32
Current: 64.59

During the past 13 years, SSY Group's highest Price-to-Free-Cash-Flow Ratio was 150.32. The lowest was 19.13. And the median was 52.59.

HKSE:02005's Price-to-Free-Cash-Flow is ranked worse than
82.13% of 498 companies
in the Drug Manufacturers industry
Industry Median: 22.61 vs HKSE:02005: 64.59

SSY Group's Free Cash Flow per Share for the six months ended in Dec. 2023 was HK$0.03. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was HK$0.07.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of SSY Group was -30.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 7.20% per year.

During the past 13 years, SSY Group's highest 3-Year average Free Cash Flow per Share Growth Rate was 53.60% per year. The lowest was -28.90% per year. And the median was -1.10% per year.


SSY Group Price-to-Free-Cash-Flow Historical Data

The historical data trend for SSY Group's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SSY Group Price-to-Free-Cash-Flow Chart

SSY Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 73.00 39.80 40.66 66.76

SSY Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.80 - 40.66 - 66.76

Competitive Comparison of SSY Group's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SSY Group's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SSY Group's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where SSY Group's Price-to-Free-Cash-Flow falls into.



SSY Group Price-to-Free-Cash-Flow Calculation

SSY Group's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=4.78/0.074
=64.59

SSY Group's Share Price of today is HK$4.78.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SSY Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

SSY Group  (HKSE:02005) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


SSY Group Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of SSY Group's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


SSY Group (HKSE:02005) Business Description

Traded in Other Exchanges
N/A
Address
Central Plaza, 18 Harbour Road, Rooms 4902-03, 49th Floor, Wanchai, Hong Kong, HKG
SSY Group Ltd is engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials. The company has two reportable segments including intravenous infusion solution and others and medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.

SSY Group (HKSE:02005) Headlines

No Headlines